These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 816167)

  • 21. Antiparkinsonian drug administration and plasma levels of penfluridol, a new long-acting neuroleptic.
    Chouinard G; Annable L; Cooper S
    Commun Psychopharmacol; 1977; 1(4):325-31. PubMed ID: 615695
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activity of a new neuroleptic, penfluridol (R-16341) in long-term treatments].
    Suárez Richards M; Mario Zelaschi N; Canero E
    Acta Psiquiatr Psicol Am Lat; 1976 Sep; 22(3):205-10. PubMed ID: 983750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penfluridol in chronic schizophrenia.
    Doongaji DR; Sheth AS; Apte JS; Datta MR; Parikh MD; Lakdawalla PD; Ratnaparkhi S; Sharma U
    Acta Psychiatr Belg; 1981; 81(4):407-15. PubMed ID: 7331844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural activity in the monkey (Macaca mulatta) of the metabolites of diazepam in man [proceedings].
    Nicholson AN; Wright CM
    Br J Pharmacol; 1976 Jul; 57(3):429P. PubMed ID: 823999
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurophysiologic and behavioral effects of certain anesthetics administered intramuscularly in the rhesus monkey (Macaca mulatta).
    Hinko PJ; Wendt W; Wollin LR; Massopust LC
    Am J Vet Res; 1970 Sep; 31(9):1661-78. PubMed ID: 4990321
    [No Abstract]   [Full Text] [Related]  

  • 27. Behavioural studies in the monkey (Macaca mulatta) with sotalol and with (+)-, (+/-)- and (-)-propranolol [proceedings].
    Nicholson AN; Wright CM
    Br J Pharmacol; 1977 Nov; 61(3):474P-475P. PubMed ID: 412542
    [No Abstract]   [Full Text] [Related]  

  • 28. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma prolactin and testosterone during penfluridol treatment.
    Nathan RS; Asnis GM; Dyrenfurth I; Halpern FS; Halbreich U; Ostrow LC; Sachar EJ
    Lancet; 1980 Jul; 2(8185):94. PubMed ID: 6105283
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduced turnover in mesolimbic dopamine neurons in 4-week-old offspring of nursing mothers treated with penfluridol.
    Engel J; Lundborg P
    Brain Res; 1976 Jul; 110(2):407-12. PubMed ID: 938954
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
    Korzycka L; Szadowska A; Pakulska W
    Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loading--a beneficial therapeutic effect using an oral long-acting drug, Penfluridol (SEMAP). A pilot study.
    Munitz H; Shalev A
    Isr J Psychiatry Relat Sci; 1986; 23(3):215-20. PubMed ID: 3570715
    [No Abstract]   [Full Text] [Related]  

  • 33. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of growth and of thymidine incorporation into DNA in Tetrahymena by chlorpromazine, pimozide and penfluridol.
    Keegan FP; Blum JJ
    J Protozool; 1983 May; 30(2):397-402. PubMed ID: 6415270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open field behavior and gross motor development in offspring of nursing rat mothers given penfluridol.
    Ahlenius S; Engel J; Hård E; Larsson K; Lundborg P; Sinnerstedt P
    Pharmacol Biochem Behav; 1977 Mar; 6(3):343-7. PubMed ID: 857256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A new long-acting psychotropic substance in oral administration: penfluridol].
    Fiume S; Ciani S
    Clin Ter; 1981 Feb; 96(3):283-301. PubMed ID: 7030582
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and pharmacological properties of new pyridine derivatives.2,6-bis-[diphenyl-(and dibenzyl)-hydroxymethyl]-piperidines.
    Kuczyński L; Wilimowski M; Bagińska M; Soloducho J
    Pol J Pharmacol Pharm; 1975; 27(5):549-53. PubMed ID: 1187457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
    Stille G
    Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of neuroleptic agents in the chronic pharmacological experiment].
    Stille G; Lauener H
    Arzneimittelforschung; 1974 Sep; 24(9):1292-4. PubMed ID: 4479794
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimuli associated with drug injections as events that control behavior.
    Goldberg SR
    Pharmacol Rev; 1975 Sep; 27(3):325-40. PubMed ID: 817305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.